DK161887C - Analogifremgangsmaade til fremstilling af en r-isomer af en 3-aryloxy-3-phenylpropylamin og farmaceutisk accetable salte heraf - Google Patents

Analogifremgangsmaade til fremstilling af en r-isomer af en 3-aryloxy-3-phenylpropylamin og farmaceutisk accetable salte heraf

Info

Publication number
DK161887C
DK161887C DK502781A DK502781A DK161887C DK 161887 C DK161887 C DK 161887C DK 502781 A DK502781 A DK 502781A DK 502781 A DK502781 A DK 502781A DK 161887 C DK161887 C DK 161887C
Authority
DK
Denmark
Prior art keywords
aryloxy
isomer
analogue
pharmaceutical
preparing
Prior art date
Application number
DK502781A
Other languages
Danish (da)
English (en)
Other versions
DK502781A (da
DK161887B (da
Inventor
Bennie Joe Foster
Edward Ralph Lavagnino
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK502781A publication Critical patent/DK502781A/da
Publication of DK161887B publication Critical patent/DK161887B/da
Application granted granted Critical
Publication of DK161887C publication Critical patent/DK161887C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK502781A 1980-11-14 1981-11-13 Analogifremgangsmaade til fremstilling af en r-isomer af en 3-aryloxy-3-phenylpropylamin og farmaceutisk accetable salte heraf DK161887C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20649880A 1980-11-14 1980-11-14
US20649880 1980-11-14

Publications (3)

Publication Number Publication Date
DK502781A DK502781A (da) 1982-05-15
DK161887B DK161887B (da) 1991-08-26
DK161887C true DK161887C (da) 1992-03-16

Family

ID=22766667

Family Applications (1)

Application Number Title Priority Date Filing Date
DK502781A DK161887C (da) 1980-11-14 1981-11-13 Analogifremgangsmaade til fremstilling af en r-isomer af en 3-aryloxy-3-phenylpropylamin og farmaceutisk accetable salte heraf

Country Status (28)

Country Link
EP (1) EP0052492B1 (enExample)
JP (3) JPS57114555A (enExample)
KR (1) KR830007508A (enExample)
AT (1) ATE6422T1 (enExample)
AU (1) AU540707B2 (enExample)
CA (1) CA1181430A (enExample)
CS (1) CS227019B2 (enExample)
CY (1) CY1350A (enExample)
DD (1) DD201139A5 (enExample)
DE (1) DE3162445D1 (enExample)
DK (1) DK161887C (enExample)
EG (1) EG15458A (enExample)
ES (1) ES8206440A1 (enExample)
FI (1) FI77018C (enExample)
GB (1) GB2087883A (enExample)
GR (1) GR75395B (enExample)
HK (1) HK16087A (enExample)
HU (1) HU185475B (enExample)
IE (1) IE52170B1 (enExample)
IL (1) IL64288A (enExample)
MY (1) MY8700709A (enExample)
NZ (1) NZ198953A (enExample)
PH (1) PH17424A (enExample)
PL (1) PL233786A1 (enExample)
PT (1) PT73982B (enExample)
RO (1) RO83309B (enExample)
SU (1) SU1068034A3 (enExample)
ZA (1) ZA817863B (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777291A (en) * 1985-02-27 1988-10-11 Eli Lilly And Company Racemization process
US4797286A (en) * 1985-11-12 1989-01-10 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
US5112619A (en) * 1985-11-12 1992-05-12 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulation
GB8823405D0 (en) * 1988-10-05 1988-11-09 Erba Carlo Spa Aryloxy-arythio-heteraryloxy-heteroarylthio-alkenylene derivatives of amines
DK258389D0 (da) * 1989-05-26 1989-05-26 Ferrosan As Aryloxyphenylpropylaminer, deres fremstilling og anvendelse
ZA921292B (en) * 1991-02-25 1993-08-23 Lilly Co Eli Treatment of lower urinary tract disorders.
WO1993000074A1 (en) * 1991-06-26 1993-01-07 Sepracor, Inc. Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
DK0612242T3 (da) * 1991-11-15 2003-10-20 Sepracor Inc Anvendelse af ren S(+)-isomer af fluoxetin til fremstilling af et medikament mod migræne
WO1993010779A1 (en) * 1991-11-26 1993-06-10 Sepracor, Inc. Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
EP0576766A1 (en) * 1992-06-29 1994-01-05 Novo Nordisk A/S Propanolamine derivatives, their preparation and use
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
WO2000051582A2 (en) 1999-03-01 2000-09-08 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
WO2000058262A1 (en) * 1999-03-29 2000-10-05 Eli Lilly And Company Stereospecific method for preparing tomoxetine and intermediates thereof
AU3877500A (en) 1999-04-09 2000-11-14 Eli Lilly And Company Methods for preparing 3-aryloxy-3-arylpropylamines and intermediates thereof
DE19955190A1 (de) * 1999-11-16 2001-06-21 Sanol Arznei Schwarz Gmbh Stabile Salze neuartiger Derivate von 3,3-Diphenylpropylaminen
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
GB0229583D0 (en) 2002-12-19 2003-01-22 Cipla Ltd A process for preparing duloxetine and intermediates for use therein
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US8545881B2 (en) 2004-04-19 2013-10-01 Eurand Pharmaceuticals, Ltd. Orally disintegrating tablets and methods of manufacture
WO2006004977A2 (en) 2004-06-28 2006-01-12 Teva Pharmaceutical Fine Chemicals S.R.L. Process for the optical resolution and recycling of tomoxetine
US7439399B2 (en) * 2004-06-28 2008-10-21 Teva Pharmaceutical Fine Chemicals Processes for the preparation of atomoxetine hydrochloride
WO2006020348A2 (en) * 2004-07-22 2006-02-23 Teva Pharmaceutical Fine Chemicals S.R.L. Polymorphs of atomoxetine hydrochloride
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
WO2006047493A2 (en) 2004-10-21 2006-05-04 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
JP2008501721A (ja) * 2005-04-05 2008-01-24 テバ ファーマシューティカル ファイン ケミカルズ ソチエタ レスポンサビリタ リミテ 安定性アトモキセチン塩酸塩、その調製方法及びその安定性の分析的調節
EP1889828A1 (en) * 2005-04-05 2008-02-20 Teva Pharmaceutical Fine Chemicals S.R.L. Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US7485754B2 (en) 2005-07-08 2009-02-03 Apotex Pharmachem Inc. Efficient method for preparing 3-aryloxy-3-arylpropylamines and their optical stereoisomers
CZ2005473A3 (cs) * 2005-07-21 2006-02-15 Zentiva, A. S Zpusob výroby hydrochloridu (R)-N-methyl-3-(2-methylfenoxy)-3-fenylpropylaminu (atomoxetinu)
EP1798215A1 (en) 2005-12-14 2007-06-20 SOLMAG S.p.A. Polymorph of atomoxetine hydrochloride in crystalline form
ITMI20061987A1 (it) * 2006-10-16 2008-04-17 Archimica Srl Processo per la sintesi di arilossipropilammine ed eteroarilossipropilammine.
WO2008062473A1 (en) * 2006-10-31 2008-05-29 Cadila Healthcare Limited Process for preparing atomoxetine hydrochloride
CN100430370C (zh) * 2006-11-03 2008-11-05 华东理工大学 一种丙胺衍生物及其在制备托莫西汀中的应用
WO2009141833A2 (en) * 2008-04-17 2009-11-26 Ind-Swift Laboratories Limited An improved process for synthesizing highly pure atomoxetine
SG10201407965XA (en) 2009-12-02 2015-02-27 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
ES2605495T3 (es) 2013-11-08 2017-03-14 Eli Lilly And Company Solución de atomoxetina
GR1008531B (el) 2014-03-21 2015-07-13 Λαμδα Φαρμακευτικα Εργαστηρια Εφαμροσμενης Ερευνας Και Αναπτυξης Α.Ε., Ποσιμα διαλυματα που περιεχουν υδροχλωρικη ατομοξετινη
EP3069715A1 (en) 2015-03-20 2016-09-21 Salmon Pharma GmbH Immediate release dosage forms of Atomoxetine
CN106916074A (zh) * 2017-02-14 2017-07-04 万特制药(海南)有限公司 盐酸托莫西汀的制备
CN110294680A (zh) * 2018-03-22 2019-10-01 北京深蓝海生物医药科技有限公司 一种盐酸阿托莫西汀的制备方法
US12642765B2 (en) 2022-12-07 2026-06-02 OWP Pharmaceuticals, Inc. Atomoxetine oral solution

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018895A (en) * 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
US4194009A (en) * 1974-01-10 1980-03-18 Eli Lilly And Company Aryloxyphenylpropylamines for obtaining a psychotropic effect
JPS5283811A (en) * 1976-01-01 1977-07-13 Lilly Co Eli Aryloxy phenyl propylamines and their salts
GB1596033A (en) * 1978-04-25 1981-08-19 Boots Co Ltd (-)-(2-methoxyphenyl) ethylamine
JPS5536403A (en) * 1978-07-28 1980-03-14 Nippon Iyakuhin Kogyo Kk Preparation of 1-benzazonine derivative
IT1113029B (it) * 1979-03-01 1986-01-20 Simes Processo per la separazione dei due isomeri ottici del moprololo e composizioni farmaceutiche dell'antipodo levogiro

Also Published As

Publication number Publication date
ATE6422T1 (de) 1984-03-15
EP0052492B1 (en) 1984-02-29
DD201139A5 (de) 1983-07-06
GB2087883A (en) 1982-06-03
PH17424A (en) 1984-08-08
PT73982A (en) 1981-12-01
JPH046699B2 (enExample) 1992-02-06
CA1181430A (en) 1985-01-22
IL64288A (en) 1985-04-30
PT73982B (en) 1983-11-23
DK502781A (da) 1982-05-15
EP0052492A1 (en) 1982-05-26
NZ198953A (en) 1984-10-19
HK16087A (en) 1987-02-27
DE3162445D1 (de) 1984-04-05
CY1350A (en) 1987-04-24
IL64288A0 (en) 1982-02-28
KR830007508A (ko) 1983-10-21
JPH037250A (ja) 1991-01-14
AU540707B2 (en) 1984-11-29
CS227019B2 (en) 1984-04-16
MY8700709A (en) 1987-12-31
JPH0369885B2 (enExample) 1991-11-05
IE812661L (en) 1982-05-14
PL233786A1 (enExample) 1982-05-24
SU1068034A3 (ru) 1984-01-15
EG15458A (en) 1986-09-30
GR75395B (enExample) 1984-07-13
JPH046698B2 (enExample) 1992-02-06
RO83309B (ro) 1984-02-28
ES507142A0 (es) 1982-08-16
JPS57114555A (en) 1982-07-16
RO83309A (ro) 1984-02-21
AU7742781A (en) 1982-05-20
IE52170B1 (en) 1987-07-22
ZA817863B (en) 1983-06-29
FI77018C (fi) 1989-01-10
DK161887B (da) 1991-08-26
HU185475B (en) 1985-02-28
ES8206440A1 (es) 1982-08-16
JPH037251A (ja) 1991-01-14
FI77018B (fi) 1988-09-30
FI813589L (fi) 1982-05-15

Similar Documents

Publication Publication Date Title
DK502781A (da) Fremgangsmaade til fremstilling af 3-aryloxy-3-phenylpropylaminer
BG41820A3 (en) Method for preparing n- (3- hydroxy- 4- piperidinyl) benzamide derivatives
ES2078962T3 (es) Nuevas 8-sustituidas-2-amino-tetralinas.
BG41821A3 (en) Method for preparing pyridyl derivatives
DK83789D0 (da) Substituerede 1,2,4-triazindioner, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse
DK152132C (da) Analogifremgangsmaade til fremstilling af derivater af 5,6,7,7a-tetrahydro-4h-thienooe3,2-caapyridin-2-on
DK483683A (da) Cyclohexan-1,3-dion-derivater og deres salte, fremgangsmaade til fremstilling deraf, herbicid og fremgangsmaade til bekaempelse af uoensket plantevaekst
DK164661C (da) Analogifremgangsmaade til fremstilling af aminoalkadien-derivater
DK439082A (da) 4-acylamino-1-aza-adamantan-forbindelser samt fremgangsmaade til fremstilling deraf
SE8603797D0 (sv) Process for the preparation of n-sulfamyl-3-(2-guanidino-thiazol-4-yl-methylthio)-propion-amidine
BG38337A3 (en) Method for preparing 6 alpha- methylhydrocortisonic derivatives
NO813084L (no) Fremgangsmaate for fremstilling av basisk substituerte fenylacetonitriler.
DK383588D0 (da) Fremgangsmaade til fremstilling af substituerede pyridylketoner
IT1193500B (it) Processo per la preparazione di 2,2'-bis/4-(1,1,3,3-tetrametilbutil) fenol/solfuro
DK344083D0 (da) Fremgangsmade til fremstilling af 3a-(substitueret phenyl) -3a,4,7,7a-tetrahydro-4,7-methanoisoindoliner
FI812773A7 (fi) Menetelmä N-/4-/(2,4-diamino-6- pteridinyyli)-metyyli/- metyyliamino/bentsoyyli/glutamiinihapon valmisvalmistamiseksi.
BG42001A3 (en) Method for preparing of 1- aryl- 2- aminoethanol derivatives
BG37524A3 (en) Method for preparing 1, 5- benzothiazepines derivatives
DK154499C (da) Fremgangsmaade til dehydrochlorering af 1,3-dichlor-5-(1,3,3,3-tetrachlor-1-methylpropyl)benzen
DK402981A (da) Fremgangsmaade til fremstilling af n-(4-( (2,4-diamino-6-pteridinyl) methyl) methylamino) benzoul) glutaminsyre
BG32114A3 (en) Method for obtaining of 3- 7, 8- dixydroxy- 6- halo- 1-
DK234283D0 (da) Fremgangsmade til fremstilling af 5z-former af 2,3,4-trinor-1,5-inter-m-phenylen-prostacyclinderivater